LPKF Opens Biolab for ARRALYZE Technology
December 6, 2021 | LPKFEstimated reading time: 1 minute
In its 45-year history, LPKF has repeatedly developed groundbreaking technologies and opened up new markets in the electronics, research and development, automotive and solar sectors. With ARRALZYE, the technology company has now developed a platform that will enable future customers in the biotechnology and pharmaceutical industries to perform single-cell screenings quickly and efficiently. ARRALYZE combines biomedical research with software and precision technology. The system can thus contribute to the accelerated development of personalized medicine, for example in the field of cancer therapies.
Dr. Robin Krueger is the head of ARRALYZE. He studied chemistry and biochemistry and worked early on with optically switchable proteins in hospital germs. "We know that tumors have individual characteristics and are influenced by genes and other physiological properties. For this reason, no one should get a standard cancer therapy, but one that is tailored to them personally." Krueger and his team of collaborators are convinced that ARRALYZE will make the development of modern medication much more cost-effective, thus enabling the widespread use of personalized medicine.
The recently opened biolab is equipped with specialized equipment for the production and analysis of cell cultures. "The biolab is essential for us to understand the needs and problems of our ARRALYZE customers and to be able to offer practical solutions," says Krueger. "This is what sets us apart from other plant growers in this complex field."
For Britta Schulz, member of the Management Board and head of the Development segment, the development of ARRALYZE technology in less than 3 years is a demonstration to LPKF's unwavering innovative strength. "With our LIDE technology for structuring glass and our expertise in optics, precision engineering and software, we are now bringing a product to market that will set new standards in biotechnology," says Schulz.
The system is thus one more step towards pushing back the previous boundaries of cell biology. The innovative approach of this process qualified ARRALYZE for inclusion in the shortlist of the prestigious Innovation Award 2021 of the State of Lower Saxony.
Suggested Items
Intel Names Naga Chandrasekaran to Lead Foundry Manufacturing and Supply Chain
07/26/2024 | IntelIntel Corporation today announced the appointment of Dr. Naga Chandrasekaran as chief global operations officer, executive vice president and general manager of Intel Foundry Manufacturing and Supply Chain organization.
We Energies, Foxconn Complete Clean Energy Project in Wisconsin
07/25/2024 | FoxconnWe Energies, a Wisconsin-based utility company of WEC Energy Group, and Hon Hai Technology Group (Foxconn) are pleased to announce the completion of a solar panel installation project at Foxconn’s Science and Technology Park in Mount Pleasant, Wisconsin.
Pragmatic Semiconductor Appoints Murthy Renduchintala to Board of Directors
07/25/2024 | PRNewswirePragmatic Semiconductor Ltd. announced the appointment of Dr. Venkata "Murthy" Renduchintala, as a non-executive director to Pragmatic's Board of Directors, effective immediately.
Altair Signs MoU With University of Nottingham to Develop Aerospace Digital Twin Project
07/25/2024 | PRNewswireAltair, a global leader in computational intelligence, has signed a memorandum of understanding (MoU) with the U.K.-based University of Nottingham for a digital twin project within the aerospace sector.
MKS’ Atotech and ESI Participate in Electronics Circuit Asia in Thailand
07/25/2024 | AtotechMKS Instruments announces its participation at the Electronics Circuit Asia 2024 in Thailand, July 24-26, highlighting its leading brands Atotech® and ESI® and related advances in advanced packaging, package substrate, and printed circuit board manufacturing.